Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 2019-A02907-50 | Other Identifier | Agence nationale de sécurité du médicament et produits de santé |
Not provided
Not provided
Not provided
COVID, death of investigator
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Chronic Rhinosinusitis (CRS) is a chronic condition with limited therapeutic options. Moreover, the pathophysiology is poorly understood. The aim of this study is to evaluate the efficacy of osteopathic manipulative treatment (OMT) in the course of this condition by applying several techniques supposed to be related to the autonomic nervous system. Our hypothesis is that these techniques could have beneficial effects on inflammation and head symptoms in CRS.
Methods:
A sample of 90 patients diagnosed by ENT specialist will be randomly assigned to the OMT group or the placebo group. The placebo procedure will consist in using light touch around the nose, on the throat and on the thorax. Treatment and placebo protocols are composed of two visits at day 0 and day 30.
A general practitioner will determine the eligibility for the study.
The outcomes include Peak Nasal Inspiratory Flow (PNIF) measured five times: at day 0, 30 (twice each, before and after treatment) and 180 (once). The two groups will be compared regarding short and long term evolution.
The evolution of symptoms will be assessed by the Sino-nasal Outcome Test (SNOT-22) seven times: at day 0, 30, 60, 90, 120, 150 and 180. This outcome will be analyzed using mixed effect modelling
A Qualitative study will be conducted in the two groups to understand the patients' experiences during care.
This protocol has been approved by a french ethic committee (Comité de Protection des Personnes Sud Ouest et Outre-Mer II, 2020.04.09).
Statistical analysis details:
PNIF middle term evolution:
If the two groups can be compared regarding their socio-demographics characteristics, a student's t-test will compare evolution (day 0 before treatment to day 30 before treatment) of the PNIF between groups.
If characteristics are different, a multivariate linear model will be applied.
PNIF long term evolution:
The same tests will be made. The evolution will be assessed between day 0 (before treatment) and day 180.
PNIF short term evolution:
The same tests will be made. The evolution will be assessed before and after treatment at day 0 and day 30.
SNOT-22 evolution:
Mixed effect model will assess the evolution of symptoms from day 0 to day 180
Response Shift detection:
For the SNOT-22, an Oort procedure will be performed in order to detect Response shift among individuals.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| OMT group | Experimental |
| |
| Placebo group | Placebo Comparator |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Osteopathic manipulative treatment | Other | Osteopaths will executed several high velocity low amplitude (HVLA) techniques on the upper thoracic spine and cervical spine. These techniques are assumed to modulate the sympathetic cervical ganglia and reduce inflammation in chronic rhinosinusitis. This procedure takes around 15 minutes. |
| Measure | Description | Time Frame |
|---|---|---|
| Change in peak nasal inspiratory flow (PNIF) | The aim of this outcome is to measure change in nasal airflow during maximal inspiration with a facial mask. | PNIF will be perform at day 0 (before treatment) and at day 30 (before treatment) |
| Measure | Description | Time Frame |
|---|---|---|
| Change in Sino-nasal Outcomes Test 22 (SNOT-22) | This is a symptom-based rhinosinusitis questionnaire. Possible total scores range from 0 to 110, where a higher score indicates worse symptoms. | Patients will complete the questionnaire at baseline (day 0), day 30, day 60, day 90, day 120, day 150 and day 180 to assess the change over time |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| sebastien cambier | Institut des Hautes Etudes Osteopathiques de Nantes | Principal Investigator |
| maxime salmon, MsC | Institut des Hautes Etudes Osteopathiques de Nantes | Study Director |
| Marie Moreau | Institut des Hautes Etudes Osteopathiques de Nantes | Study Chair |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Cabinet ORL du Maine | Le Mans | 72000 | France |
Not provided
| ID | Term |
|---|---|
| D000096825 | Rhinosinusitis |
| D002908 | Chronic Disease |
| D012220 | Rhinitis |
| D012852 | Sinusitis |
| ID | Term |
|---|---|
| D012141 | Respiratory Tract Infections |
| D007239 | Infections |
| D010254 | Paranasal Sinus Diseases |
| D009668 | Nose Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D026301 | Manipulation, Osteopathic |
| ID | Term |
|---|---|
| D026201 | Musculoskeletal Manipulations |
| D000529 | Complementary Therapies |
| D013812 | Therapeutics |
| D026741 | Physical Therapy Modalities |
Not provided
Not provided
Not provided
Not provided
Not provided
The care provider knows the assignment of patient. In order to know if the blinding was effective, at the end of each treatment, patient will have to tell if they were in the placebo or the OMT group
|
| Placebo manipulation | Other | The osteopath will lay hands without movement on the nose, the throat and the thorax of patients. This procedure takes around 15 minutes. |
|
| Patient-reported experience of care |
Individual interviews will enable to document the personal experience during effective or placebo treatment. |
| Interview will occur at day 180 |
| Sort term change in peak nasal inspiratory flow (PNIF) | The aim of this outcome is to measure change before and after each treatment in nasal airflow during maximal inspiration with a facial mask. | PNIF will be perform at day 0 (before and after treatment), day 30 (before and after treatment) |
| long term change in peak nasal inspiratory flow (PNIF) | The aim of this outcome is to measure change in nasal airflow during maximal inspiration with a facial mask from base line to day 180. | PNIF will be perform at day 0 (before treatment) and at day 180. |
| D012140 |
| Respiratory Tract Diseases |
| D010038 | Otorhinolaryngologic Diseases |
| D020969 | Disease Attributes |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D012046 | Rehabilitation |